Felecia Smith
Nurse Practitioner · Windcrest, TXNPI 1427249457
Payments from drug & device makers
Across 342 payments — averaging $25.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- AbbVie$2K
- UCB, Inc.$1K
- Johnson & Johnson$1K
- Pfizer$546
- AstraZeneca$512
- plus $2K from 18 others
What the payments were for
- Food & beverage$8,58498%
- Education$1382%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 93 | $2,235 |
| AbbVie | 57 | $1,519 |
| UCB, Inc. | 34 | $1,146 |
| Johnson & Johnson | 43 | $1,080 |
| Pfizer | 26 | $546 |
| AstraZeneca(2 entities) | 25 | $512 |
| Lilly USA, LLC | 14 | $300 |
| Novartis | 3 | $251 |
| Aurinia Pharma U.S., Inc. | 10 | $208 |
| Fresenius Kabi USA, LLC | 6 | $167 |
| Janssen Scientific Affairs, LLC | 2 | $142 |
| Octapharma USA, Inc. | 6 | $125 |
| Organon | 5 | $110 |
| ANI Pharmaceuticals, Inc. | 4 | $84 |
| Boehringer Ingelheim | 3 | $60 |
| E.r. Squibb & Sons, L.L.C. | 2 | $42 |
| GSK | 2 | $38 |
| Astellas Pharma US Inc | 1 | $35 |
| Celltrion USA Inc. | 1 | $27 |
| Tonix Medicines, Inc. | 1 | $22 |
| Neurometrix Inc | 1 | $20 |
| Genentech USA, Inc. | 1 | $19 |
| Sandoz | 1 | $17 |
| Scilex Pharmaceuticals Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,721 in reported general payments places this provider in the 95th percentile of 5,422 nurse practitioner providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 18 | $142,902 |
| Naloxone Hcl | 17 | $1,083 |
| MethotrexateMethotrexate Sodium | 57 | $950 |
| Mycophenolate Mofetil | 17 | $831 |
| Hydroxychloroquine Sulfate | 27 | $815 |
| Tramadol Hcl | 35 | $561 |
| Prednisone | 72 | $517 |
| Leflunomide | 12 | $313 |
| Gabapentin | 22 | $280 |
| Allopurinol | 15 | $200 |
| Duloxetine Hcl | 14 | $191 |
| Pregabalin | 14 | $175 |
| Alendronate Sodium | 17 | $159 |
| Tizanidine Hcl | 19 | $157 |
| Celecoxib | 16 | $152 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Windcrest
- Cecilia DavisAustin$262K
- Melanie MorrisHouston$254K
- Stephanie BrownHarlingen$235K
- Brittney MisercolaKilleen$223K
- Roger ChapmanTyler$211K
- Kelly BrassilHouston$194K
- Corrie BerkSan Antonio$155K
- Samantha OnealDallas$133K
- Monica WhiteLongview$118K
- Onna FeuchterSouthlake$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.